Filter
1676
Filtered Results: 1676
Text search:
registration
of
drugs
Featured
Recommendations
144
New Publications
558
Language
Document type
No document type
1151
Guidelines
189
Studies & Reports
170
Manuals
63
Strategic & Response Plan
61
Training Material
17
Situation Updates
10
Fact sheets
10
Resource Platforms
4
Brochures
1
Countries / Regions
India
162
Kenya
72
Sierra Leone
46
Uganda
45
Nigeria
44
Nepal
43
Ethiopia
41
South Africa
41
Ghana
40
Rwanda
38
Malawi
35
Tanzania
33
Liberia
32
Bangladesh
31
Western and Central Europe
31
Global
31
Myanmar / Burma
27
Zambia
24
Namibia
23
Africa
23
Ukraine
22
Botswana
19
Philippines
17
Eastern Europe
17
Latin America and the Carribbean
16
Zimbabwe
15
Syria
15
Cambodia
14
Indonesia
13
Lesotho
13
South Sudan
12
Asia
12
Mozambique
11
South–East Asia Region
11
Congo, Democratic Republic of
9
Senegal
6
Pakistan
6
Eswatini/ Swaziland
6
Colombia
6
Russia
6
Tajikistan
5
Haiti
4
Jordan
4
Lebanon
4
Sudan
4
Benin
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Albania
4
Cameroon
3
Iraq
3
Afghanistan
3
Germany
3
Brazil
3
North Macedonia
3
Sri Lanka
3
West and Central Africa
3
Venezuela
3
Moldova
3
Iran
3
Georgia
3
Burkina Faso
2
Saudi Arabia
2
Argentina
2
Greece
2
Libya
2
Angola
2
Chile
2
Middle East and North Africa
2
Bhutan
2
Palestine
2
Armenia
2
Laos
2
Turkmenistan
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Somalia
1
Egypt
1
Thailand
1
Gambia
1
China
1
Malaysia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Ecuador
1
Bolivia
1
Madagascar
1
Yemen
1
Paraguay
1
Fiji
1
Djibouti
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
878
Clinical Guidelines
129
Public Health
71
Women & Child Health
60
Key Resources
34
Pharmacy & Technologies
28
Capacity Building
22
Toolboxes
TB
170
HIV
165
Pharmacy
74
Mental Health
71
AMR
70
COVID-19
53
Conflict
42
NTDs
34
Caregiver
33
Refugee
25
NCDs
23
Disability
22
Rapid Response
15
Global Health Education
13
Ebola
10
Natural Hazards
10
Specific Hazards
8
Planetary Health
8
Polio
4
Health Financing Toolbox
4
Cholera
3
Zika
3
Social Ethics
3
South Sudan
2
Annex 5, WHO Technical Report Series 1010, 2018
Accessed August, 2017
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It inc...
Training for staff working at DR-TB management centres.
Training modules
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc....
A survey of prevention, testing and treatment policies and practices
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss ... confidence in health professionals, manufacturers and distributors and in health systems. In an effort to protect people’s health, the WHO Regional Director for Africa, Dr Matshidiso Moeti, has proposed a strategy aimed at strengthening National Medicine Regulatory Authorities (NMRAs) in order to ensure that only safe, good quality and effective medical products are available.
Tropical Medicine and International Health volume 21 no 1 pp 101-107 january 2016
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update ... the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release i...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and ...
The National Tuberculosis Programme (NTP) of Rwanda (known as TB & ORD Division/IHDPC/RBC) is preparing to write their next National Strategic Plan and for this reason Rwanda was selected as a country to received technical assistance (TA) to conduct...
